SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vertex Pharmaceuticals (VRTX)
VRTX 469.90-1.2%Jan 30 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: tnsaf7/18/2012 11:27:44 PM
   of 1169
 
You are invited to participate in:

Vertex Pharmaceuticals Incorporated
Second Quarter 2012 Financial Results Call

July 30, 2012 at 5:00 p.m. Eastern Daylight Time

To listen to the call via telephone, please dial:

U.S./Canada
(877) 250-8889

International
(720) 545-0001

Conference Code
10939223

To view the webcast and listen to the call on the internet, please visit:
www.vrtx.com

Please dial in 5-10 minutes prior to the scheduled start time. A question and answer period will follow management’s presentation. An accompanying PowerPoint presentation will be available at www.vrtx.com, Events & Presentations.

The call will be available for replay via telephone commencing July 30, 2012 at 8:00 p.m. EDT running through 5:00 p.m. EDT on August 13, 2012. The replay phone number for the U.S. and Canada is (855) 859-2056. The international replay number is (404) 537-3406 and the conference ID number is 63676268.

The webcast will be available for replay on the Internet commencing July 30, 2012 at 8:00 p.m. EDT running through 5:00 p.m. EDT on August 6, 2012. You may access the replay at www.vrtx.com, Events & Presentations. Alternatively, Vertex is providing a podcast MP3 file available for download on the Vertex website, www.vrtx.com, until August 13, 2012.

Vertex Pharmaceuticals’ press release related to its financial results for the second quarter 2012 will be sent to you prior to the conference call.

We look forward to your participation.
Investor Relations Team
Vertex Pharmaceuticals Incorporated
(617) 444-6668
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext